Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains
Raynaud’s Phenomenon is a vascular affliction resulting in pain and blanching of the skin caused by excessive and prolonged constriction of arterioles, usually due to cold exposure. Nifedipine is a vasodilatory calcium channel antagonist, which is used orally as the first-line pharmacological...
Збережено в:
| Автори: | , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
MDPI AG
2019-11-01
|
| Серія: | Pharmaceutics |
| Предмети: | |
| Онлайн доступ: | https://www.mdpi.com/1999-4923/11/11/594 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|